Clinical Trials Logo
  1. Home
  2. Ascites Hepatic
  3. NCT05578573

Comparison Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis

Ascites Hepatic Clinical Trial

Official title:
Comparison of Success Rate and Complication Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis in Cirrhotic Patients With Ascites

Clinical Trial Summary

Comparison of success rate and complication between conventional angiocatheter versus new anchoring device (KARAHOC) used for paracentesis in cirrhotic patients with ascites.

Clinical Trial Description

This study is a multi-center, prospective, interventional study, in which subjects who meet the selection criteria are registered at each institution during the study period from the date of research approval. Regardless of the order, paracentesis using KARAHOC and conventional angiocatheter will be performed once in all patients. The criteria for successful paracentesis is set as 3L or more of ascites drainage. During paracentesis, albumin will be infused in all patients. Heart rate and blood pressure will be measured before the procedure and right after the completion of drainage, and 30 minutes later. The incidence of complications will be compared between two methods. In addition, patient and operator satisfaction will be investigated using a visual analogue scale. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05578573
Study type Interventional
Source Soonchunhyang University Hospital
Contact
Status Enrolling by invitation
Phase N/A
Start date January 17, 2022
Completion date December 31, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05014594 - Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT Phase 2
Recruiting NCT05793983 - S100A8/A9 and Innate Immunity in Liver Disease
Recruiting NCT05928624 - A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients N/A
Recruiting NCT04221672 - The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy Phase 3
Completed NCT04384523 - A Study of OsrHSA in Adult Healthy Male and Female Volunteers Phase 1
Recruiting NCT05346393 - HRS-AKI Treatment With TIPS in Patients With Cirrhosis N/A
Recruiting NCT04322201 - Continuous Passive Paracentesis for Intra-abdominal Hypertension N/A
Completed NCT05013502 - Empagliflozin in Diuretic Refractory Ascites Phase 1
Withdrawn NCT04109144 - Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis Phase 2
Recruiting NCT05726747 - QOL and Sarcopenia in Patients With Ascites
Completed NCT04569565 - Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory Ascites N/A
Completed NCT03459378 - Outcome After TIPS
Recruiting NCT06256432 - Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome Phase 2
Recruiting NCT05999773 - SGLT-2 Inhibitors in the Treatment of Ascites
Completed NCT03107091 - Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites Phase 2
Terminated NCT05765253 - Achieving Portal Access With Scorpion Post-Approval Study (APASS) N/A
Recruiting NCT05960006 - A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis
Completed NCT03191851 - Evaluation of 'Melody' Paracentesis Device for Ascites Therapy N/A
Recruiting NCT05490888 - Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics Phase 1
Not yet recruiting NCT06224023 - Predictive Values of Presepsin Levels in ASciteS in Patients With Chronic Liver Failure